We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Verona Pharma Plc | LSE:VRP | London | Ordinary Share | GB00BYW2KH80 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 55.00 | 45.00 | 65.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMVRP
RNS Number : 8462T
Verona Pharma PLC
11 January 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
1. Identity of the issuer or Verona Pharma Plc the underlying issuer of existing shares to which voting rights are attached: (ii) ------------------------------------------------------------- --------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ------------------------------------------------------------------------------------ An acquisition or disposal of voting rights X ---------------------------------------------------------------- ------------------ An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ---------------------------------------------------------------- ------------------ An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ---------------------------------------------------------------- ------------------ An event changing the breakdown of voting rights ---------------------------------------------------------------- ------------------ Other (please specify): --------------------------------------------------------- ----- ------------------ 3. Full name of person(s) Novo A/S subject to the notification obligation: (iii) ----------------------------------------------------------- ----------------------- 4. Full name of shareholder(s) (if different from 3.):(iv) ----------------------------------------------------------- ----------------------- 5. Date of the transaction 30 December 2016 and date on which the threshold is crossed or reached: (v) ----------------------------------------------------------- ----------------------- 6. Date on which issuer 10 January 2017 notified: ----------------------------------------------------------- ----------------------- 7. Threshold(s) that is/are Above 12% crossed or reached: (vi, vii) ----------------------------------------------------------- ----------------------- 8. Notified details: ------------------------------------------------------------------------------------------------------------------------------ A: Voting rights attached to shares (viii, ix) ------------------------------------------------------------------------------------------------------------------------------ Class/type Situation previous Resulting situation after the triggering of to the triggering transaction shares transaction if possible using the ISIN CODE ------------- -------------------------------------------- ----------------------------------------------------------------- Number Number Number Number of voting % of voting of of of shares rights rights (x) Shares Voting Rights ------------- -------------------------- ---------------- ---------------- ------------------------- -------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------- --------- ----------- ------------ ---------------- ------------ ----------- --------- --------- Ordinary Shares (0.1p) GB00B06GSH43 221,203,271 221,203,271 323,203,271 323,203,271 12.59% -------------------------- ---------------- ---------------- ------------ ----------- --------- --------- B: Qualifying Financial Instruments ------------------------------------------------------------------------------------------------------------------------------ Resulting situation after the triggering transaction ------------------------------------------------------------------------------------------------------------------------------ Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ----------------- ------------------------ ------------------ ----------------------------------------- ------------------ C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ------------------------------------------------------------------------------------------------------------------------------ Resulting situation after the triggering transaction ------------------------------------------------------------------------------------------------------------------------------ Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) --------------- ----------- --------------- -------------- ------------------------------ ------------------------------- Nominal Delta --------------- ----------- --------------- -------------- ------------------------------ -------------------- --------- Total (A+B+C) ------------------------------------------------------------------------------------------------------------------------------ Number of voting rights Percentage of voting rights ------------------------------------------------------------- --------------------------------------------------------------- 323,203,271 12.59% ------------------------------------------------------------- --------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ---------------------------------------------------------------------------------- Proxy Voting: ---------------------------------------------------------------------------------- 10. Name of the proxy holder: -------------------------------------------------------------- ------------------ 11. Number of voting rights proxy holder will cease to hold: -------------------------------------------------------------- ------------------ 12. Date on which proxy holder will cease to hold voting rights: -------------------------------------------------------------- ------------------ 13. Additional information: -------------------------------------------------------------- ------------------ 14. Contact name: Heather Ludvigsen -------------------------------------------------------------- ------------------ 15. Contact telephone number: +45 3527 6576 -------------------------------------------------------------- ------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLGGURUGUPMGBU
(END) Dow Jones Newswires
January 11, 2017 02:00 ET (07:00 GMT)
1 Year Verona Pharma Chart |
1 Month Verona Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions